Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an


Journal

Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176

Informations de publication

Date de publication:
Jan 2022
Historique:
pubmed: 5 9 2020
medline: 6 1 2022
entrez: 5 9 2020
Statut: ppublish

Résumé

The recent COVID-19 pandemic caused by SARS-CoV-2 has recorded a high number of infected people across the globe. The virulent nature of the virus makes it necessary for us to identify promising therapeutic agents in a time-sensitive manner. The current study utilises an

Identifiants

pubmed: 32885740
doi: 10.1080/07391102.2020.1814870
doi:

Substances chimiques

Antiviral Agents 0
Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

438-448

Auteurs

Rameez Jabeer Khan (RJ)

Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P., India.

Rajat Kumar Jha (RK)

Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P., India.

Ekampreet Singh (E)

Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P., India.

Monika Jain (M)

Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P., India.

Gizachew Muluneh Amera (GM)

Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P., India.

Rashmi Prabha Singh (RP)

Department of Biotechnology, IILM College of Engineering & Technology, Greater Noida, U.P., India.

Jayaraman Muthukumaran (J)

Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P., India.

Amit Kumar Singh (AK)

Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, U.P., India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH